WGRX (Wellgistics Health) LT-Debt-to-Total-Asset: 0.43 (As of Mar. 2026)


What is Wellgistics Health LT-Debt-to-Total-Asset?

Wellgistics Health WGRX -2.37% LT-Debt-to-Total-Asset is 0.43 as of Mar. 2026. The stock has 6 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Wellgistics Health's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.43.

Wellgistics Health's long-term debt to total assets ratio increased from Mar. 2025 (0.13) to Mar. 2026 (0.43). It may suggest that Wellgistics Health is progressively becoming more dependent on debt to grow their business.

Wellgistics Health  (NAS:WGRX) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Wellgistics Health LT-Debt-to-Total-Asset Related Terms

Wellgistics Health LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Wellgistics Health's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wellgistics Health LT-Debt-to-Total-Asset Chart

Wellgistics Health Annual Data
Trend Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
0.00 1.04 0.22 0.43

Wellgistics Health Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.20 0.25 0.43 0.43

Wellgistics Health LT-Debt-to-Total-Asset Calculation

Wellgistics Health's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=13.127/30.459
=0.43

Wellgistics Health's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=12.991/30.128
=0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.43 mean?
Wellgistics Health (WGRX) has a LT-Debt-to-Total-Asset of 0.43 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Wellgistics Health and its competitors.
Is Wellgistics Health's LT-Debt-to-Total-Asset too high?
Wellgistics Health's current LT-Debt-to-Total-Asset is 0.43.
How does Wellgistics Health's LT-Debt-to-Total-Asset compare to HEWA and BLMH?
Wellgistics Health's LT-Debt-to-Total-Asset of 0.43 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Healthcare Providers & Services company?
A good LT-Debt-to-Total-Asset depends on the Healthcare Providers & Services industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Wellgistics Health and its competitors. Wellgistics Health's current LT-Debt-to-Total-Asset is 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellgistics Health stock overvalued right now?
Wellgistics Health (WGRX) has a current LT-Debt-to-Total-Asset of 0.43. The current LT-Debt-to-Total-Asset is 0.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Wellgistics Health (WGRX), the current LT-Debt-to-Total-Asset is 0.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Wellgistics Health Business Description

Address 3000 Bayport Drive, Suite 950, Tampa, FL, USA, 33607
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.